Pharmacovigilance
mercredi 12 juin 2024
Sessions parallèles
Sessions parallèles
•
S43
•
16h00
>
17h30
•
Pharmacovigilance
•
Amphi D
Sessions parallèles
Modérateurs : TBC
Conférence invitée
16h00 Signal Detection and Prioritisation: New Frontiers in pharmacovigilance - Andrew BATE (GSK)
Communications orales
•
22
•
CO-043 - Sudden sensorineural hearing loss after mRNA COVID-19 vaccination: early safety signal generation using disproportionality analysis on a nationwide pharmacovigilance database
>
H.
Haleh
Bagheri
•
70
•
CO-044 - Descriptive study of the adverse effects of gabapentinoids in the national pharmacovigilance database used off label in children for neuropathic pain
>
C.
Claire
De Canecaude
•
137
•
CO-045 - Evaluation of the adequacy of Urate Lowering Therapy prescriptions in patients with chronic kidney disease: results from the CKD-REIN cohort
>
S.
Solène
Laville
•
147
•
CO-046 - Medication use during breastfeeding: A 5-year experience in the pharmacovigilance center of Lyon
>
B.
Blandine
Bertin
•
150
•
CO-047 - Azithromycin dispensing and associated iatrogenesis during the COVID-19 pandemic in France: a descriptive retrospective study
>
J.
Justine
Perino
•
328
•
CO-048 - Antibiotics Adverse Effects: analysis of reports made in Nouvelle-Aquitaine between 2017 and 2022
>
N.
Nina
Laviec
|